GGGCX
Price
$46.28
Change
-$0.07 (-0.15%)
Updated
May 9 closing price
Net Assets
182.31M
RNPHX
Price
$62.89
Change
+$0.12 (+0.19%)
Updated
May 9 closing price
Net Assets
142.07B
Ad is loading...

GGGCX vs RNPHX

Header iconGGGCX vs RNPHX Comparison
Open Charts GGGCX vs RNPHXBanner chart's image
Gabelli Global Growth C
Price$46.28
Change-$0.07 (-0.15%)
VolumeN/A
Net Assets182.31M
American Funds New Perspective R5E
Price$62.89
Change+$0.12 (+0.19%)
VolumeN/A
Net Assets142.07B
GGGCX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GGGCX vs. RNPHX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGGCX is a Buy and RNPHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 142B vs. GGGCX (182M). RNPHX pays higher dividends than GGGCX: RNPHX (0.74) vs GGGCX (0.23). GGGCX was incepted earlier than RNPHX: GGGCX (25 years) vs RNPHX (9 years). GGGCX (2.32) is less costly to investors than RNPHX (0.56). GGGCX is a more actively managed with annual turnover of: 26.00 vs. RNPHX (24.00). RNPHX has a lower initial minimum investment than GGGCX: RNPHX (250) vs GGGCX (1000). GGGCX annual gain was more profitable for investors over the last year : 7.90 vs. RNPHX (5.52). GGGCX return over 5 years is better than : 62.62 vs. RNPHX (47.52).
GGGCXRNPHXGGGCX / RNPHX
Total Expense Ratio0.900.56161%
Annual Report Gross Expense Ratio2.320.56414%
Fund Existence25 years9 years-
Gain YTD-0.7712.360-33%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets182M142B0%
Annual Yield % from dividends0.230.7431%
Returns for 1 year7.905.52143%
Returns for 3 years59.5628.03212%
Returns for 5 years62.6247.52132%
Returns for 10 years67.93N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HL5.150.27
+5.53%
Hecla Mining Company
BTAI1.53N/A
N/A
BioXcel Therapeutics Inc
SSNC77.61-0.10
-0.13%
SS&C Technologies Holdings
NRIX9.50-0.14
-1.45%
Nurix Therapeutics
SGMO0.70-0.02
-2.72%
Sangamo Therapeutics